tive parents know how desirable it is. Their purely personal desires are, among other considerations, the result of their religious and ethical beliefs and their wish for a particular child balanced against the risk of life and health. Presumably the twentieth child at age 40 would not be so welcome as the first at age 20. Within the framework of the law and medical ethics, the parents should make the decision for pregnancy and for therapeutic abortion. Whatever the physician's feelings and beliefs, they have no bearing on such decisions. In this summary, I am reporting my present opinion without intruding my religious or other personal bents.
Since we base our information on statistics, we should remember their weaknesses. It is obvious that, whatever the method of classification, individuals differ within each subclassification; in fact, each patient deserves special subclassification. We know that statistics lag. They do not keep up with progress in treatment. Accuracy requires a series of many cases which, if personally observed, are slowly accumulated. It is less obvious that statistics obtained from hospital records of cases followed by different individuals may not include deaths before delivery or in late puerperium because of transfer of cardiac patients from obstetrical to medical services.
Patients may avoid or leave clinics where therapeutic abortions are not performed. Those that remain are a selected group. Those that go elsewhere may be worse than average risks. It is more accurate to base our information on risk of one year of pregnancy and puerperium compared with risk of living for one year not pregnant. Such statistics should be gathered from patients followed for a number of years before, after and during pregnancies.
Disturbances in respiration and circulation, in contour of the heart, fluid retention, and other circulatory phenomena with associated subjective symptoms that appear and change in varying degrees during normal pregnancy, are likely to confuse diagnosis and subclassification. The trained examiner soon learns from experience to make allowances for these disturbances.
RHEUMATIC IHEART DISEASE
Many of the appropriate questions can be answered firmly for patients with rheumatic heart disease. Various clinics have reported maternal mortality for patients with rheumatic heart disease as less than 1 per cent to more than 3 per cent. This is fairly solid information. It can be compared with the risk of normal patients. Statistics indicate that the average maternal mortality rate for pregnancy and puerperium in cardiac patients of better subclassifications (including classes I and II of the New York Heart Association classification) are only slightly higher than the mortality rate for one year of living not pregnant. For the minority who are severely handicapped (classes III and IV of the New York Heart Association classification) and have had signs of congestive heart failure under usual living conditions or during previous pregnancies, and for those with a complicating disease dangerous in itself, the risk of death during a year of pregnancy and puerperium is several times as great as for a year of living not pregnant. For those who have developed auricular fibrillation, the risk of pregnancy becomes still higher. Those that are classified in the majority (classes I and II) will be referred to as "favorable" cardiacs, others as "unfavorable."
The danger of heart failure and of death is, statistically, materially higher if the patient is 35 years of age or more. It is generally believed that parity, per se, is not a determining factor in maternal mortality of women with rheumatic heart disease. Treatment markedly influences over-all maternal mortality among patients with rheumatic heart disease. Although the maternal mortality rate for the great majority, classified as "favorable" by any sound method, should be only slightly greater than the rate for one year of living, not pregnant, this is true only if the pregnant patient seeks and receives proper care. If not, no matter how skilled the strictly obstetrical care, the risk of death becomes nearly as great as if they were in the minority or "unfavorable" group. When cardiac clinics have been established in obstetric clinics, the maternal death rate has fallen impressively. This improvement has been in the "favorable" group. Although the treatment for congestive failure and other conditions has probably improved, the maternal mortality for the "unfavorable" patients has not improved in my experience. If the cardiac patient is severely handicapped, the unavoidable load of pregnancy leads to a high maternal death rate even with the best care.
One of the oldest cardiac clinics in an obstetrical hospital has reported a maternal death rate for "unfavorable" cases of 16 per cent for the first 15 years of the cardiac clinic.
For the next 10 years, it was 18 per cent. The overall death rate for patients with rheumatic heart disease has continued to improve in this clinic. This is not due entirely to improved control and care of the "favorable" cardiac patients but relates to the decrease in proportion of "unfavorable" cases. The latter fact is noteworthy. Is the smaller proportion of unfavorable cases due to better care of cardiacs in general during the last 30 years following development of general cardiac clinics and more education of medical lay people? Is it because with education, fewer "unfavorable" cardiacs undertake pregnancy? Or is it because, as some believe, rheumatic fever is milder or better controlled?
It is believed by some observers that pregnancy, if survived without disaster, does not affect the course of rheumatic heart disease. This and the belief that rheumatic heart disease tends to progress in severity leads logically to prognostication based on the number of years since the first attack of rheumatic fever. The value of this hypothesis is limited because: (1) it is difficult to determine the time of onset; almost half of my private patients seen for the first time when adults, do not give a clear history of rheumatic fever; and (2) it has been convincingly shown that in children, the prognosis is much better during a 10-year period if the patient, immediately after the initial attack of rheumatic fever, has less than minimal evidence of rheumatic heart disease.
Age of the pregnant patient appears to me to be fully as useful as years elapsed since the first attack of rheumatic fever. In estimating prognosis, age is easily determined. Its effect is universal. However, both date of onset of first attack of rheumatic fever and age of the patient have only limited prognostic value. It must be remembered that wide variation in the course of rheumatic heart disease is common.
It is not possible to deduce clearly from the literature the role of active rheumatic fever in the course of pregnancy in patients with rheumatic heart disease. Though it has been suspected that pregnancy protects patients against activation of rheumatic fever, there is no clear evidence for this concept. Some of my acquaintances who emphasize the role of rheumatic fever in determining the entire life course of adults with rheumatic heart disease believe that smouldering rheumatic fever is an important factor in prognosis in pregnancy. The general belief among experienced cardiologists of my acquaintance in this country is that pregnancy has little influence in activating rheumatic fever. Recent reports, however, of postmortem studies in small series, or in isolated cases, suggest that rheumatic fever in pregnancy, though rare, is the determining factor in maternal mortality of those with rheumatic heart disease. One report expressed belief that active rheumatic fever is a fatal complication in pregnancy. In my experience, recognizable rheumatic fever is rare in pregnancy, and only very slightly more common than in comparable nonpregnant patients, and the course is the same. It is a mistake to believe that rheumatic fever in pregnancy is uniformly fatal. The average age of my patients is just under 28 years. Recurrences have been many times more common in pregnancies among the young patients under 22 years of age than among the older ones. Possibly differences in average age of the patients or environmental conditions explain the discrepancy between my experience and opinions expressed in reports from other countries.
We have not enough data to be able to evaluate the desirability of interruption of pregnancy because of rheumatic fever. Whatever the role of active rheumatic fever in pregnancy of women with rheumatic heart disease, we need not feel that it alters the importance of other factors. Amount of heart damage, effort capacity, complicating disease, personality factors, age, and elapsed time since first attack of rheumatic fever, all are more or less proven to be significant. The powerful beneficial effect of proper prenatal care on the immediate maternal and infant mortality rates in pregnancy of women with rheumatic heart disease is established for all time. Since so many factors have been shown to influence prognosis, the natural temptation to overemphasize any one of them to make subclassification simple should be resisted. In the "'favorable" groups, infant mortality is nearly the same as in the whole population. It is 30 per cent or more in the "unfavorable" group.
Does pregnancy tend to provoke or hasten invalidism and shorten life? Certainly it does in some cases. It is not clear that this is generally true if pregnancy is survived and has provoked no complication which leaves permanent damage. The incidence of heart failure occurring for the first time during pregnancy and puerperium appears clearly higher than for a year of living not pregnant. Statistics show that prognosis becomes poorer as soon as congestive heart failure has appeared, but prognosis may be little affected for many cases in which failure is induced by unusual stress and is promptly relieved after stress is avoided. Much has been made of reports that women with rheumatic heart disease who have borne children and have survived pregnancy live as long or slightly longer than women with rheumatic heart disease who have not been pregnant. This is interesting, indeed, but does not permit the conclusion that pregnancy, per se, does not shorten life expectancy, other factors being equal. They are not equal. Obviously those that marry are a selected group. The unhandicapped are more likely to marry than those who are invalided, some of whom are confined to institutions. This is indirectly but convincingly supported by vital statistics on married versus single women in five-year periods, in the general population. During the years when the majority of marriages occur, the difference is great. Mortality rates are much higher among unmarried women. Furthermore, it seems likely that the average married woman has an easier life, particularly after age 35 when invalidism and death among rheumatic heart disease patients become frequent. Often the cardiac patient receives considerable assistance from her husband and grown children. Most of the spinsters are self-supporting and life becomes no easier.
Statistics which show that the more pregnancies a cardiac patient has had, the older she is at death, are seldom interpreted to indicate that a cardiac who wants to live a long time should have all the children she can, though this has indeed been implied. Proof is still lacking that pregnancy, per se, does not shorten life expectancy even when deaths during pregnancy and puerperium are excluded.
The question, "Shall I live long enough to see my children grow up and may I expect to be able to care for them/" can be answered fairly firmly. However highly we value available statistical reports that those that have married and had pregnancies live at least as long as those that have not had pregnancies, we must not, in advising patients, let this obscure the fact that expectation of sustained capacity for ordinary effort and for life are materially shortened by rheumatic heart disease. Occasional reports familiar to internists, but not to the laity, continue to confirm this. Nor should we withhold the fact from the laity that early invalidism and midlife death are not inevitable.
Occasional reports emphasize the fact that some women with rheumatic heart disease function well and live to good age. Because of expected early invalidism and premature death, some physicians urge that cardiac patients be advised to have their pregnancies only in early life. Studies by psychologists show that the average female with rheumatic heart disease is psychosexually retarded and less fitted physically and emotionally for all the demands of married life. There are numerous exceptions, of course. But the average patient is more dependent than comparable normal persons. She should be.
Since the majority of young women with rheumatic heart disease marry and the great majority of those married undertake pregnancy, and since success depends in part on planned living and cooperation from the patient's family, timely education for all concerned is needed. Treatment of pregnancy for cardiacs logically begins in the period before marriage. Surgery for Rheumatic Valvulitis during Pregnancy There are a few reports of successful surgical treatment of the mitral valve during pregnancy. No one could be satisfied with this as a plan for usual procedure. The need for surgery during pregnancy should be avoidable, except in rare circumstances, if cardiacs receive timely education.
Nonpregnant patients with a high degree of mitral stenosis, normal rhythm and nearly normal heart size, but with attacks of acute pulmonary edema and severe dyspnea and rapid heart rate, sometimes with chest pain and hemoptysis, are believed to benefit greatly by prompt surgical treatment. Pregnancy is especially likely to provoke the symptoms just described. Typically, the seizures recur until the pregnancy is over and then disappear, at least temporarily. Some patients die undelivered. Most of the cases that I know about have had interruption of the pregnancy because of increasingly violent symptoms recurring with increasing frequency, with cessation of the attacks following termination of pregnancy. A few, who have had little restriction of activity until the seizures appeared, whose seizures began late in pregnancy and who were then treated with great care, have attained successful term delivery. It is a dramatically dangerous syndrome, familiar to most internists but far from common. Clearly defined cases occur in hardly more than 1 in 100 pregnancies of women with rheumatic heart disease. Some consider that surgical treatment of the valve disease is indicated promptly when this syndrome appears in the early months of pregnancy if the condition of the patient can be rendered satisfactory for the operation. The alternative is to interrupt the pregnancy. From my experience, it is hard to justify withholding both interruption and immediate surgical treatment of the valve when these symptoms appear early and recur in spite of medical treatment. Since interruption may be expected to abolish the symptoms for a long time if the patient is kept under control, and since surgical treatment of the valve, without the complicating load of pregnancy and after ample time for convalescence, should make later pregnancies safer, interruption first and surgery later seems the safer method. There is uncertainty at present concerning the immediate response to surgery, and uncertainty in regard to the time required for optimum improvement after operation.
In the far more numerous patients with rheumatic heart disease who do not belong in the group discussed above, but who are seen in early pregnancy in chronic congestive failure or who have early failure that responds slowly to standard treatment, the choice between immediate surgery, interruption with surgical treatment later, or allowing pregnancy to continue, relying on medical care alone, is indeed difficult. We can only compare immediate surgical mortality with mortality rates of patients in similar subclassifications. At present, it appears to me that the choice must be made rather blindly. We need to know much more about the course during the months immediately following cardiac surgery of young women operated on when not pregnant. Certainly not all of them show immediate improvement. Some improve after a considerable delay. It is reasonable to believe that recovery from surgical treatment would be affected by pregnancy. The fact that some cases have been operated on during pregnancy successfully does not alter the fact that, in general, recovery from a stress is retarded by addition of other stresses. It is good sense, at this time, to keep an open mind, and to recognize the need of educating patients to have their cardiac status assessed before undertaking pregnancy.
CONGENITAL CARDIOVASCULAR DEFECTS
Statistics are necessarily less satisfactory for these than for the common cardiac diseases.
Patent Ductus Arteriosus
The maternal mortality rate is probably no better than for patients with rheumatic heart disease, namely, between 3 and 4 per cent. The same may be said less confidently for infant mortality. Those with large hearts, pulmonary blood vessel congestion, low effort capacity, high systolic and wide pulse pressure, probably tolerate pregnancy less well than those in whom these changes are not as extreme. There is evidence that the blood pressure of these patients rises materially some days before and remains elevated until term delivery and then drops suddenly after delivery, though this does not occur in every instance. There is no such drop in blood pressure after delivery in normal women after uncomplicated delivery. A few patients with patent ductus arteriosus have been reported in whom death followed promptly after delivery. There is some evidence that a right-to-left shunt developed at the time of the drop in systemic blood pressure and was the cause of sudden death. Postmortem examinations in some of these cases have shown a very large patent ductus. As might be anticipated, a moderate number of patients who have been successfully treated surgically for patent ductus have done well in pregnancy.
Should patients already pregnant have surgical treatment of this anomaly at once? Perhaps. It has been done successfully. Recovery from this operation should be easier than from surgical treatment of rheumatic mitral stenosis. Improvement in the circulation should be immediate. Healing of the vital vascular organs should be prompt and should not make heavy demands on the body. There is not apparent, therefore, any great advantage to be gained by interruption of the pregnancy first and surgical treatment later. Obviously this situation need not occur if patients have adequate premarital physical examinations and plan their pregnancies.
Septal Defects and Pulmonary Stenosis
Pregnancies among cardiacs with ventricular septal defects have not been reported as frequently as among those with patent ductus. From my experience and from available data, the maternal and infant mortality are approximately the same for both conditions. It is generally believed that patients with auricular seplal defects, and those with Lutembacher's Syndrome tolerate pregnancy well. A few experiences make me hesitate to accept this dictum when there is marked cardiac enlargement. The same may be said for patients with pulmonary valve stenosis. For some reason, there are less data for pulmonary stenosis in pregnancy than for the two defects previously discussed. In my experience, sexual development has been more retarded and fertility less lasting among those with pulmonary stenosis. So few instances of pregnancy in women with Tetralogy of Fallot have been reported that such rare occurrences must be treated without the aid of adequate experience. Sudden, severe symptoms directly after emptying the uterus attributed to aggravation of the right-to-left shunt have been reported. Little is known about the course of pregnancy in patients who have had surgical treatment for Tetralogy of Fallot.
Relation of Maternal Anomalies to Fetal
Congenital Cardiac Anomalies Deaths have been reported of patients with patent ductus, Roger's disease or pulmonary stenosis, with the same cardiovascular defect found in the fetus at postmortem examination. Some of these women had been previously delivered of healthy infants. Women with developmental cardiovascular defects thus face the chance, however slight, of a specific defect in the infant that the mother with acquired heart disease does not face. There are also reported illstances of similar cardiovascular defects in father and child.
Coarctation of Aorta
Pregnancy for patients with coarctation of the aorta has received considerable attention.
Some observers have reported a high maternal death rate. But where the maternal mortality percentage is based on the number of pregnancies rather than on the number of individual patients, the mortality rate is not alarmingly increased. It has been noted that women with coarctation of the aorta stand approximately an even chance of having a lower blood pressure during pregnancy than at other times, and are likely to say that they are more comfortable when pregnant. There is an almost equally good chance that blood pressure will rise alarmingly in the latter part of pregnancy, at times accompanied by lowered effort capacity, spells of breathlessness, and cncephalopathy. Cases have been reported of lower blood pressure in one pregnancy, higher pressure in a later pregnancy, and vice-versa. Dissection of the aorta. Among the few reported maternal fatalities, dissection of the aorta is prominently mentioned as the immediate cause. A few have survived the dissection and lived for months. It has been suggested that patients with coarctation of the aorta should be delivered by caesarian section before labor begins to avoid the apparent strain of labor. This rule, if adopted, might also apply for pregnancies in women who have had surgical treatment of coarctation of the aorta.
The group with dissection of the aorta without accompanying coarctation is of interest. Nearly half of the reported women of child-bearing age who have died of dissection of the aorta were pregnant or in the puerperium. Only a few had coarctation of the aorta. Hypertension is often present, but a large number had neither coarctation nor hypertension and showed characteristic medial necrosis of the aorta. Atherosclerosis was not the underlying pathology. There is, then, apparently some association between disease of the media and pregnancy. The mobilization of cholesterol in pregnancy has been suggested as a possible factor but without supporting evidence.
It would seem that a thorough study of the effect of pregnancy on the aorta is desirable. This would have a direct bearing on indications for surgical treatment of coarctation of the aorta during pregnancy. Successful surgical treatment of coarctation in the early months of pregnancy has been performed. However, one case, not yet formally reported, which was operated upon in the first few weeks of pregnancy with good immediate results, ended in rupture of the aorta in the eighth month. Though the author believes that the last trimester of pregnancy, or delivery, are the periods most dangerous for women with coarctation of the aorta, rupture or dissection of the aorta due to disease of the media alone may occur at any time in pregnancy. There have been reported a small number of patients who were treated surgically for coarctation of the aorta and who had subsequent successful pregnancies.
Comment
Many rare congenital cardiovascular defects and pregnancy have, of course, been reported and discussed, but data are insufficient to warrant conclusions. How much pregnancies affect the life course of women with congenital cardiovascular defects is less clearly known than the effect of pregnancy on acquired heart diseases. We must wait many years before really satisfying statistics on pregnancy for surgically treated cases of the various cardiovascular defects can be gathered. Such data should be collected, however, particularly by clinics and individuals performing such surgery on large numbers of patients.
Women with congenital cardiovascular defects should reasonably have the same prenatal observation and general care as female cardiac patients in general. I make it a rule to be present at delivery and for a while thereafter when my patients with an arteriovenous communication are delivered. If distressing symptoms appear, binding of extremities, abdomen and limbs or tourniquets on the limbs to reduce venous flow, or dropping the legs, or all three and other appropriate emergency measures, may be in order. At any rate, those responsible for the cardiovascular condition of the patient should remember that there is a time of special danger for the mother directly after delivery. BACTERIAL ENDOCARDITIS (ACUTE AND SUBACUTE) In my experience before the era of modern treatment, bacterial endocarditis occurred in slightly less than 1 per cent of pregnancies with rheumatic heart disease or congenital cardiovascular defects. Since then, the incidence has declined. Treatment during pregnancy is fairly satisfactory, especially if the disease is discovered early and before there is general depletion and widespread pathology. I believe that treatment during pregnancy is somewhat less successful than under usual conditions. In my limited number of cases, pregnancy apparently hastened the progress of the disease. In spite of early diagnosis and modern treatment, two patients died with multiple, widespread hemorrhages; both fetuses died in utero from intracranial hemorrhage. In contrast, there had been almost no difficulty in controlling symptoms promptly in comparable young, nonpregnant women and young men, in whom the diagnosis was made equally early and before widespread symptoms appeared. It is worthwhile to continue study of this subject until statistics are adequate. If it were clear that pregnancy interferes with treatment materially, prompt therapeutic abortion should improve the chance for the patient's survival and future successful pregnancies.
Subacute bacterial endocarditis is somewhat more likely to be discovered in the few months following pregnancy than during pregnancy. At delivery and in early puerperium some form of prophylactic therapy against bacterial endocarditis is generally advocated for patients with rheumatic and congenital cardiovascular disease. How long this treatment should be continued has not yet been sufficiently studied.
After cure of subacute bacterial endocarditis pregnancies are generally satisfactory. There appears to be little reason to fear pregnancy in recovered cases because of this danger alone, though recurrences have been reported. Prophylactic treatment throughout pregnancy and early puerperium has been advocated.
ESSENTIAL HYPERTENSION
The course of pregnancy for patients with essential hypertension is not as well documented as pregnancy for patients with rheumatic heart disease. This is probably due in part to the difficulty in defining and subclassifying essential hypertension, of differentiating it from pre-eclampsia-eclampsia, and in identifying the patient who has both. Since obstetricians are constantly alert for hypertension, they have developed special skill in the recognition of pure or complicated pre-eclampsia-eclampsia, and knowledge of its course. Nevertheless, it is the internist or cardiologist who is commonly asked by the patient with chronic hypertension for information concerning the effect of pregnancy.
A fair number of statistical reports are available on maternal and infant mortality. The maternal death rate appears to be somewhat lower than for patients with rheumatic heart disease. As in rheumatic heart disease, the maternal death rate is pleasingly low in the first and second groups, as subclassified on a scale of four, but high in the much smaller groups with severe essential hypertension classified as group III or IV.
There is general agreement that a large percentage, often placed at 30 per cent or more, develop pre-eclampsia. However, it is often difficult to be confident that symptoms developing late in pregnancy are due to preeclampsia and not to the progress of essential hypertension. But careful studies continue to reduce this difficulty. The criteria for differential diagnosis cannot feasibly be discussed here, though they are of interest to internists. For example, studies in patients with (1) essential hypertension, (2) pre-eclampsia, and (3) both together, indicate interestingly that cardiac output is not increased in 1, slightly increased in 2, and materially increased in 3. Circulating blood volume apparently is somewhat below average in women with toxemias when compared with normal women at the same stage of pregnancy.
There is general agreement that there is a heavy infant mortality, particularly among patients who are in the severe subclassifications. There is general agreement that timely interference with the pregnancy is a particularly important factor in infant survival. Some believe that essential hypertension does not materially increase the risk to mother and child. Unquestionably, however, adequate experience shows that pregnancy may cause alarming symptoms in some patients with essential hypertension, and that where the symptoms are alarming, there is a heavy infant mortality. It also can be accepted as proven that there is high maternal mortality among those with essential hypertension who have enlarged hearts, and who have had symptoms of congestive heart failure or seizures of paroxysmal dyspnea, or have evidence of severe nephritis. Statistics indicate that the age of the patient is a potent factor in mortality rates.
Impressive statistics indicate that the condition of the eyegrounds is the single most important point in prognosis for infant mortality, and that regardless of the status of the mother on other findings, if the eyegrounds are in class I or class II, the prognosis for the infant is good. If in class III or IV, the prognosis for the infant is bad.
It is also generally believed that skillful prenatal control, especially by obstetricians, favorably affects infant and maternal mortality of patients with essential hypertension. Maternal and infant mortality rates in essential hypertension have improved during recent years. It has been reported that where prenatal weight control and sodium restriction have been enforced, there is marked lowering of the maternal and fetal mortality rates whereas in localities where this treatment has not been carried out, no such improvement has occurred. Some impressive statistics gathered many years ago showed that the same may be said for care of oral sepsis.
Hormonal treatment during pregnancy, as a preventive measure, has been followed by improved statistics in some clinics.
It is certain that the factors which are responsible for the development of severe symptoms of essential hypertension in pregnancy are not yet as sharply defined as the factors related to congestive heart failure in rheumatic heart disease. It has been stressed, for example, that pre-eclampsia and eclampsia, more or less intermingled with essential hypertension, are much more common in unwanted pregnancies, for example, in illegitimacy, and in the third pregnancy. In general, the emotional and personality factors in the course of essential hypertension have attracted more attention in relation to pregnancy than in relation to rheumatic heart disease.
How does pregnancy affect the life course of patients with essential hypertension? From the above considerations, the conclusion must be that, other factors being equal, pregnancy shortens life expectancy statistically to some extent. In one large series of women with essential hypertension studied by me but not yet reported, the percentage in the severe subgroups was higher in women who had borne children than in those of the same age who were childless.
Recent reports suggesting that essential hypertension does not shorten life expectancy materially except in approximately 5 per cent of subjects should not lessen the force of wellknown reports nearly 20 years ago of hundreds of women who had hypertension-albuminuria during pregnancy and survived, but who, after being followed for more than seven years, were found to have a mortality rate five times higher than that for women of the same age in the community at large. Eighty per cent of the deaths were cardiovascular. One cannot at present distinguish clearly each good and bad risk before pregnancy.
Medical treatment of essential hypertension in pregnancy from the point of view of the internist is the treatment of essential hypertension in general. Patients deserve careful and continued observation, protection against fatigue, needless weight gain, malnutrition and complicating disease, just as do those with rheumatic heart disease, and, so far as is feasible, protection from all stresses known to affect hypertension. Many consider pregnancy a formidable stress for patients with essential hypertension.
Does pre-eclampsia-eclampsia cause heart disease, and if so is it permanent? I believe that the normal heart may be affected but apparently less so than many other organs. The pathology is not specific. Cardiac output is only slightly increased. Cardiac deaths in patients with uncomplicated pre-eclampsia and eclampsia must be rare if, indeed, they occur. Nevertheless the heart not infrequently appears to be enlarged in those believed to have uncomplicated, severe pre-eclampsia or eclampsia. There are gallop sounds; the rate may be rapid with pulsus alternans; there usually is rapid breathing, often rales and generalized edema. Sometimes acute edema of the lungs occurs. Circulating blood volume is, however, usually surprisingly low, lower on the average than for normal patients at the same stage of pregnancy; the usual evidences of congestive heart failure associated with high circulating blood volume are absent. When, however, pre-eclampsia complicates rheumatic heart disease, signs of congestive heart failure usually appear quickly. Electrocardiographic studies have failed to show convincing evidence of severe myocardial change in uncomplicated cases in my experience, although a few case reports have described such evidence.
Careful follow-up of somewhat small groups, divided so far as possible into (1) mild pre-eclampsia, (2) severe pre-eclampsia, and (3) eclampsia, showed that patients in the first group exhibited a high incidence of hypertension and hypertensive heart disease; many individuals in this group were believed to have essential hypertension and were wrongly classified as mild, but pure, pre-eclampsia. In patients in the second group, where evidences of pre-eclampsia were more definite and fewer patients with essential hypertension were wrongly included, there was much less evidence of hypertension and heart disease. Those in the third group, probably correctly classified as pure, uncomplicated eclampsia, almost without exception had normal hearts and blood pressure, a dramatic finding in view of the severe symptoms during the height of the eclampsia. It indicates that pure preeclampsia-eclampsia seldom if ever causes permanent heart disease.
PHYSIOLOGY OF CIRCULATION DURING PREGNANCY
The physiology of the circulation during pregnancy will be briefly summarized. Widely known studies reported more than 10 years ago revealed increased circulating blood volume and cardiac output, moderate hemodilution, increased heart rate, hurried circulation, a slight fall in blood pressure and increased pulse pressure, returning toward normal in the final phase of pregnancy. The basal oxygen consumption was found to be increased slightly.
There was a slight increase in the vital capacity and a greater' increase in minute-volume of respiration. Studies of many other allied phenomena were also available. A fairly distinct outline of the circulatory changes and of the total load on the circulation became apparent. Of particular importance was the usually slow development of increased work of the heart until during the early part of the last trimester when it abruptly increased, with subsequent levelling off until the last three or four weeks of pregnancy, when the previous increase in cardiac work and output gradually lessened to a material degree until term. This curve resembled a curve based, in a long series of cases, on the time in pregnancy when symptoms of heart failure first appeared. The lightening of the load in the four weeks before term had long been noted but not generally appreciated. Demonstration and measurement by indirect tests attracted attention and led to modification of the obstetric care of patients with cardiovascular complications. In particular, there were fewer interruptions for cardiovascular reasons during the last trimester and, therefore, fewer hysterotomies. Since then, there have been numerous similar studies by improved technics that have essentially confirmed the conclusions previously indicated. The changes vary in extent and in timing, but there is always an increase in the load which partly disappears near term in normal pregnancy. Later studies have extended into the puerperium and indicate a gradual return toward normal over several weeks.
The abrupt changes that accompany emptying the uterus and detachment of the placenta with sudden removal of the circulatory system of the infant must affect the mother profoundly. The average patient who is in heart failure when delivered, instead of experiencing immediate relief after delivery, is worse. This obtains even when delivery is precipitate and apparently effortless. Some patients with arteriovenous communication suddenly develop or increase a venous-arterial shunt.
Distressing symptoms after delivery may be due to an abrupt fall, reported to average 250 cc., in vital capacity consequent to suddenly decreased intra-abdominal pressure. Many other disturbances are probably also strongly implicated; these include increase in congestion of pulmonary vascular bed at term and delivery. Further investigations concerning the extent and course of this increased congestion of pulmonary blood vessels are highly desirable. Does it appear constantly? Does it appear before labor begins? Release of pressure on the pelvic and leg veins and contraction of the emptied uterus seemingly flood the maternal veins and lead promptly to pulmonary congestion. After detachment of the placenta, amniotic fluid may invade the veins in significant quantity and increase pulmonary congestion. Obstruction of small pulmonary vessels by the particulate matter in amniotic fluid, though only rarely believed to be a significant danger, may be important in hardpressed cardiac patients with chronically engorged pulmonary blood. vessels. Some believe that the distress of cardiac patients after delivery is provoked by use of drugs that have a pressor effect. But distress appears in hard-pressed cardiacs even when delivery is precipitate and appears effortless and when no pressor drugs have been administered. Catheterization during labor and delivery is wistfully regarded as a likely method for illuminating these matters. So far, very few reports have appeared, to my knowledge. Technical and other difficulties and fear of disaster have discouraged nearly all with whom I have discussed this method of study. Many simple studies by left auricular catheterization some time before delivery and some time after delivery have been reported. They throw little light on the problem of what happens during delivery and immediately or soon thereafter.
If we knew the time and extent of pulmonary congestion before, during and after delivery, and the mechanism thereof, it is possible that we might control the process sufficiently to aid the occasional woman who goes into labor or who must be delivered while in heart failure.
Certainly, we can consider methods for restoring intra-abdominal pressure to reduce critical respiratory embarrassment after delivery, such as our every day procedures in treating emphysema. Flooding of maternal veins after release of pelvic pressure can be controlled, to some extent, by tourniquets and by dropping the legs. These maneuvers have been tried, but surely are not in general use and need to be supported by suitable studies. Even the chance of amniotic embolism might be partly controlled if the need for this were clear. If indirect support for these procedures is not to be expected, it nevertheless would be well to assess their possible benefit. Disturbed fluid balance in pregnancy, and also in phases of the menstrual cycle and in menopause, is receiving somewhat belated attention by internists, particularly in women with mitral stenosis. In some women, the disturbances are profound. The great interest in the physiology of fluid retention and edema in heart disease should clearly include this problem. In obstetric clinics, interest in fluid retention is intense. Progress through continued study of hormone behavior seems likely. This surely concerns cardiologists. The mechanism of blood dilution, increased circulating blood volume, and hurried circulation in pregnancy, needs study. These phenomena, though normal in pregnancy, may not be desirable in cardiac patients and might be influenced. More active study of the physiology of the circulation in pregnancy, delivery and puerperium also may lead to improved treatment of every day congestive heart failure, particularly in women.
